Production (Stage)
Regeneron Pharmaceuticals, Inc.
REGN
$603.26
$14.922.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.63% | -16.90% | -1.18% | 9.87% | 17.41% |
| Total Receivables | 6.49% | 9.61% | 9.36% | 11.63% | 2.02% |
| Inventory | 17.59% | 19.64% | 17.80% | 14.59% | 11.97% |
| Prepaid Expenses | 12.34% | -9.88% | -28.31% | 86.92% | 2.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 36.36% | -- |
| Total Current Assets | -6.89% | -4.20% | 3.75% | 12.76% | 11.60% |
|
|
|||||
| Total Current Assets | -6.89% | -4.20% | 3.75% | 12.76% | 11.60% |
| Net Property, Plant & Equipment | 11.09% | 14.03% | 10.81% | 9.77% | 8.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 10.23% | 10.59% | 10.12% | 15.66% | 14.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 40.66% | 42.05% | 46.23% | 49.91% | 42.01% |
| Total Assets | 9.24% | 14.15% | 16.41% | 17.71% | 14.34% |
|
|
|||||
| Total Accounts Payable | 5.09% | 30.15% | -7.32% | 2.63% | 11.98% |
| Total Accrued Expenses | -6.31% | 6.75% | 0.13% | 8.50% | 15.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 59.47% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 19.86% | 36.78% | 18.61% | 53.77% | 21.21% |
| Total Other Current Liabilities | 19.86% | 36.78% | 18.61% | 53.77% | 21.21% |
| Total Current Liabilities | -0.40% | 15.22% | 1.73% | 13.02% | 15.51% |
|
|
|||||
| Total Current Liabilities | -0.40% | 15.22% | 1.73% | 13.02% | 15.51% |
| Long-Term Debt | 0.08% | 0.08% | 0.07% | 0.07% | 0.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | 17.17% | 0.00% | 0.00% | 0.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.37% | 70.27% | 82.83% | 100.34% | 43.46% |
| Total Liabilities | 10.56% | 18.27% | 11.81% | 18.70% | 12.40% |
|
|
|||||
| Common Stock & APIC | 10.46% | 13.23% | 12.90% | 13.12% | 12.69% |
| Retained Earnings | 15.73% | 16.19% | 17.83% | 17.22% | 15.99% |
| Treasury Stock & Other | -25.17% | -20.05% | -13.53% | -13.06% | -15.20% |
| Total Common Equity | 8.88% | 13.02% | 17.75% | 17.44% | 14.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.88% | 13.02% | 17.75% | 17.44% | 14.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.88% | 13.02% | 17.75% | 17.44% | 14.88% |
|
|
|||||